Economic burden of chronic kidney disease
- 26 March 2008
- journal article
- review article
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 14 (3), 422-434
- https://doi.org/10.1111/j.1365-2753.2007.00883.x
Abstract
To define the cost of care and evaluate interventions associated with improving outcomes and delaying the progression of chronic kidney disease (CKD). Using the PubMed database, a systematic review of the literature was conducted describing (i) the cost of care associated with treating earlier stages of CKD, and (ii) the role of early referral, erythropoiesis-stimulating proteins and anti-hypertensive agents in improving clinical outcomes and reducing the cost of CKD. The higher costs associated with treatment of the CKD population are largely due to higher rates and duration of comorbidity-driven hospitalizations. Studies suggest that early referral to a nephrologist, use of erythropoiesis-stimulating proteins and anti-hypertensive agents may be associated with better outcomes and lower costs. In some instances, however, higher target haemoglobin levels could have harmful effects in CKD patients. The substantial costs incurred during earlier stages of CKD increase markedly during the transition to renal replacement and remain elevated thereafter. An increase in awareness among health care providers may result in more timely interventions. More proactive management, in turn, can lead to improved clinical and economic outcomes through the slowing of disease progression and prevention of comorbidities.Keywords
This publication has 81 references indexed in Scilit:
- Identification and Referral of Patients With Progressive CKD: A National StudyAmerican Journal of Kidney Diseases, 2006
- Retard persistant au suivi néphrologique de l’insuffisance rénale chroniqueLa Presse Médicale, 2006
- Effects of late referral to a nephrologist in patients with chronic renal failureNephrology, 2005
- Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care OrganizationArchives of Internal Medicine, 2004
- Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal diseaseDiabetes & Metabolism, 2004
- Renoprotective Effect of Losartan in Comparison to Amlodipine in Patients with Chronic Kidney Disease and Hypertension-a Report of the Japanese Losartan Therapy Intended for the Global Renal Protection Hypertensive Patients (JLIGHT) StudyHypertension Research, 2004
- Health care utilization among patients with chronic kidney diseaseKidney International, 2002
- Antihypertensive Treatment with and without Benazepril in Patients with Chronic Renal InsufficiencyPharmacoEconomics, 2002
- Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patientsNephrology Dialysis Transplantation, 2001
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997